Inspiration Healthcare Group strengthens AIM presence within FTSE AIM 100 Index

Highlights

• Inspiration Healthcare Group plc appoints Cavendish Capital Markets as joint broker

• The Company continues operating within the UK medical technology and neonatal care sector

• Presence aligned with FTSE AIM market indices and healthcare equipment segment

Inspiration Healthcare Group plc appoints Cavendish Capital Markets as joint broker, reinforcing its position within the AIM medical technology space and neonatal care sector.

The medical technology sector in the United Kingdom plays a vital role in supporting clinical care, hospital infrastructure, and patient outcomes across public and private healthcare systems. Companies operating within this space develop and supply equipment that enables clinicians to deliver specialised treatment in critical care environments. Inspiration Healthcare Group plc (LSE:IHC) operates within this sector, focusing on neonatal intensive care medical technology and related healthcare solutions. The Company is listed on the Alternative Investment Market and is associated with the FTSE AIM 100 Index and the FTSE AIM UK 50 Index, which form part of the broader UK equity landscape that also includes the FTSE 100 Index and the FTSE 350 Index.

Within the wider market structure, healthcare technology companies such as Inspiration Healthcare Group plc contribute to the diversity of UK listed businesses represented across benchmarks including the FTSE universe and the FTSE AIM All-Share Index. These indices provide context for sector classification and market participation rather than serving as performance indicators.

Inspiration Healthcare Group plc operates as a global medical technology company headquartered in the United Kingdom, with a strategic emphasis on neonatal care. The Group designs, manufactures, and markets specialised equipment intended to support the earliest stages of life, addressing the complex needs of premature and critically ill infants.

Joint broker appointment strengthens advisory structure

Inspiration Healthcare Group plc has announced the appointment of Cavendish Capital Markets Limited as joint broker with immediate effect. This appointment complements the ongoing role of Panmure Liberum, which continues to act as nominated adviser and corporate broker to the Company. The joint broker structure aligns with common practices among AIM listed companies seeking broader advisory coverage and market engagement.

Cavendish Capital Markets brings experience in supporting UK growth companies across multiple sectors, including healthcare and technology. Its appointment alongside Panmure Liberum expands the Company’s access to capital markets expertise, institutional communication channels, and advisory resources. Panmure Liberum remains responsible for nominated adviser duties, ensuring continuity in regulatory and corporate advisory support.

The appointment has been formally communicated through a regulatory announcement, providing transparency to shareholders, market participants, and stakeholders. Contact details for senior management, advisers, and media representatives have been outlined to support ongoing dialogue and engagement.

Alignment with FTSE AIM indices and UK market framework

As an AIM listed company, Inspiration Healthcare Group plc (IHC) forms part of the ecosystem represented by the FTSE AIM 100 Index and the FTSE AIM UK 50 Index. These indices track a selection of companies admitted to the AIM market and reflect sector diversity across healthcare, technology, industrials, and services.

The AIM indices sit alongside broader UK benchmarks such as the FTSE 100 Index, which represents large capitalisation companies, and the FTSE 350 Index, which combines constituents of the FTSE One Hundred and FTSE Two Hundred and Fifty indices. Together, these benchmarks provide a structured framework for understanding the composition of the UK equity market.

Healthcare and medical technology companies contribute to this framework by offering exposure to innovation driven industries. Within the broader FTSE All-Share Index context, AIM listed healthcare businesses add depth to the UK market by addressing specialised clinical needs and supporting healthcare infrastructure development.

Inspiration Healthcare Group plc’s alignment with AIM related indices reflects its operational scale and sector focus rather than its position within larger capitalisation benchmarks. This structure supports participation within a growth oriented regulatory environment while maintaining visibility across healthcare focused market segments.

Core operations and neonatal intensive care expertise

Inspiration Healthcare Group plc specialises in the development and supply of neonatal intensive care medical devices. The Group’s product portfolio includes both proprietary branded products and complementary distributed technologies designed for use in neonatal units. These products support clinicians in providing respiratory support, monitoring, and therapeutic care to premature and critically ill newborns.

The Company’s own branded range includes advanced capital equipment used in hospital settings, as well as consumable and single use medical devices. These products are designed to integrate into neonatal intensive care workflows, supporting continuous care throughout a patient’s hospital stay.

Manufacturing and technology operations are based in Croydon, South London, where the Group operates a dedicated facility supporting product development, testing, and assembly. This location serves as a central hub for innovation and quality control. In addition, the Company maintains operations in Melbourne, Florida, supporting its activities within the United States healthcare market.

Distribution is structured to serve both domestic and international customers. In the United Kingdom and Ireland, products are supplied directly to hospitals and healthcare providers. In international markets, the Group works with an established network of distribution partners, enabling access to healthcare systems across multiple regions. This approach supports the availability of neonatal medical technology across a wide geographic footprint.

Corporate communications and sector presence

Inspiration Healthcare Group plc maintains a structured corporate framework supported by senior management, advisory partners, and communications specialists. Leadership responsibilities are held by the Chief Executive Officer and Chief Financial Officer, supported by corporate advisers and public relations professionals.

Walbrook PR Limited acts as media and investor relations adviser, facilitating communication between the Company and external stakeholders. This includes engagement with the financial media, healthcare industry participants, and the wider investment community.

Within the healthcare sector, neonatal intensive care represents a highly specialised area requiring technical precision, regulatory compliance, and collaboration with clinical professionals. Companies operating in this field contribute to the broader healthcare equipment industry, which forms part of the UK’s industrial and scientific landscape.

Medical technology companies are also referenced within thematic discussions around income focused equities, including references to FTSE dividend stocks, although dividend characteristics vary depending on sector structure and corporate policy. Inspiration Healthcare Group plc continues to operate within this established market environment, supported by its joint broker arrangement and presence within AIM related indices.